- Ingird Gafanhão
- Maria Vara
- Olga Smolentseva
- Oscar Haffen Lamm
- Valliant Campagne
CRISPR gene-edited drugs are coming to market
CRISPR Therapeutics is one of the leaders in the gene-editing space, focusing on maximizing the value of CRISPR/Cas gene editing to develop multiple therapeutic candidates. The broad range of applications for the company's core technology is reflected in an extensive pipeline that combines programs
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.